LMP7

Molecular group: 
Leucocyte effector mechanisms and proteases
Molecule/Cell: 
LMP7
Plasmodium strain: 
Plasmodium yoelii 17NL
pRBC infection titer: 
2,5 x 10^4
Mouse genetic background (Con): 
C57BL/6
Level of backcrossing: 
N.I.
Experimental treatment group (EG): 
LMP7 -/-
Lethal infection (Con): 
No
Lethal infection (EG): 
No
Pathology (Con): 
N.I.
Pathology (EG): 
N.I.
Parasitemia (EG vs Con): 
Decreased peak and faster clearance
Additional phenotypes (EG vs Con): 
N.I.
Refs: 
Duan et al., 2013, PLoS One